Abstract LB173: APVO603: A Dual 4-1BB and OX40 Bispecific Approach Utilizing ADAPTIRTMtechnology Designed to Deliver a Conditional T Cell/nk Response Against Solid Tumors
Cancer Research(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Cancer Research(2021)